Researchers identify a potential biomarker of Parkinson's disease progression
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...
Make this one lifestyle change to lower your Parkinson’s disease risk
There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.
EurekAlert!3d
Researchers at TAU discovered a potential new target for developing effective treatments for Parkinson's disease
The study was backed by the Aufzien Family Center for the Prevention and Treatment of Parkinson's Disease at ... Does ...
GlobalData on MSN2d
DMTs are major clinical research focus for Parkinson’s disease, analysis shows
Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...
News Medical on MSN2d
New biomarker could help predict Parkinson’s disease progression
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.
Armed robbery in Revesby3d
Biomarker Found for Parkinson's Disease Progression
In addition, they often have milder symptoms, especially in the early stages ... have a different prognosis and do not ...
One Parkinson's disease early warning sign that often gets overlooked - not tremors
Among the symptoms, losing one's sense of smell could be an easily missed early indicator. The University of Auckland ...
clinicaltrialsarena7d
Parkinson’s disease clinical research in 7MM focuses on disease-modifying agents
Treatments targeting alpha-synuclein aggregation account for 26% of the 7MM' pipeline disease-modifying therapies for ...
The Pharma Letter4d
Growing emphasis on disease-modifying therapies in Parkinson’s
The Parkinson’s disease (PD) therapeutic landscape is heavily genericized, leaving substantial unmet needs in neuroprotective ...
pna2d
Researchers identify key protein in Parkinson’s disease’s spread
Israeli scientists have identified a promising new factor in the pathology of Parkinson’s disease that could pave the way for ...
psychiatryadvisor.com13d
Pimavanserin Treatment Timing Affects Parkinson Disease Psychosis Resolution
Early initiation of pimavanserin among patients with Parkinson disease psychosis were more likely to experience complete symptom resolution.
The Financial Express3d
Parkinson’s disease clinical research in seven major markets focuses on disease-modifying agents
(Image Credits: Pixabay) Parkinson’s disease (PD) therapeutic landscape is heavily genericized, leaving substantial unmet needs in neuroprotective and disease-modifying therapies (DMTs). With current ...